Nanotechnology in development of drug delivery system

International Journal of Pharmaceutical Sciences

Volumn 3, Issue 1, 2012, Pages 84-96

  Maravajhala, Vidyavathi ^a   Papishetty, Sandya ^a   Bandlapalli, Sarika ^a  

^a INSTITUTE OF PHARMACEUTICAL TECHNOLOGY   (India)

Author keywords

High shear homogenization; Milling method; Polymerization technique; Solid lipid nanoparticles

Indexed keywords

CARBON NANOHORN; CARBON NANOTUBE; CERAMIC NANOPARTICLE; CYCLODEXTRIN NANOSPONGE; DENDRIMER; GOLD NANOPARTICLE; MAGNETIC NANOPARTICLE; NANOCRYSTAL; NANODIAMOND; NANOFILM; NANOHORN; NANOPARTICLE; NANOSHELL; PROTEIN NANOPARTICLE; QUANTUM DOT; SOLID LIPID NANOPARTICLE; UNCLASSIFIED DRUG;

DRUG DELIVERY SYSTEM; HIGH TEMPERATURE PROCEDURES; HUMAN; MICROEMULSION; MICROFLUIDIC ANALYSIS; NANOANALYSIS; NANOEMULSION; NANOFABRICATION; NANOPHARMACEUTICS; NANOSUSPENSION; PARTICLE SIZE; POLYMERIZATION; PRECIPITATION; REVIEW; SPRAY DRYING; SUPERCRITICAL FLUID; SUSPENSION;

EID: 84859042820     PISSN: None     EISSN: 09754725     Source Type: Journal    
DOI: None     Document Type: Review

References (77)

1. Nilesh J, Ruchi J, Navneet T, Brham Prakash G, Deepak Kumar J. Nanotechnology: A Safe And Effective Drug Delivery Systems. Asian Journal of Pharmaceutical and Clinical Research 2010, vol.3, issue 3. 159-165.
2. Rakesh P.P. Nanoparticles and its Applications in Field of Pharmacy. Available at http://www. Pharmainfo.net/reviews/ Nanoparticles-and-its-applications-field-phamacy.2008.
3. nd Edition. 88-105.
4. Eric A, Robert G, Eric D. Drug-Loded Nanoparticle Preparation Methods and Drug Targeting Issues. Eur.j.Pharm.Biopharm., (1993), 39(5) 173-91.
5. Harsimran K, Archana C, Inderpreet K, Kashmir S, Lalit M.B.(2010)Transportation of Drug- Gold Nanocomposites by Actinomyosin Motor System. Journal of Nanoparticle Research. Available at www.springerlink.com/index/D25H45525W57565K.pdf, 2010.
6. Indira T.K, Lakshmi P.K, Magnetic Nanoparticles: A Review. International Journal of Pharmaceutical Sciences and Nanotechnology, 2010, vol.3, Issue 3.1035-42.
7. Mohsen J, Zahra B. Protein nanoparticle: A Unique system as drug delivery vehicles. African Journal of Biotechnology, 2008.vol. 7(25), 4926-34.
8. Pragathi. S, Ashok. S, Sateesh. M. Solid Lipid Nanoparticles: A Promising Drug Delivery Technology International Journal of Pharmaceutical Sciences and Nanotechnology, 2009.vol.2, issue 2.509-16.
9. Mukherjee. S, Ray. S and Thakur R.S. (2009) Solid Lipid Nanoparticles: A Modern Approaching in Drug Delivery System. Indian journal of pharmaceutical sciences, 71(4) 349-58.
10. Suresh G, Manjunath K, Venkateswarlu V, Satyanarayana V. Preparation, Characterization and In vitro & In vivo Evaluation of Lovastatin Solid Lipid Nanoparticles. AAPS PharmSciTech 2007, 8(1); Article 24.E1-E9.
11. Vyas SP. Theory and Practice in Novel Drug Delivery System. CBS pulisher, First edition. 2009, 299-21.
12. Jens-U A H J, Muller R, Nanocrystal Technology, Drug Delivery and Clinical Applications. International Journal of Nanomedicine. 2008, 3(3): 295-310.
13. Patravale V.B, Abijit A, Kulkarni R.M, Nanosuspensions: A Promising Drug Delivery Strategy. Journal of pharmacy and pharmacology, 2004, 56:827-40.
14. Xiaohui Pu, Jin Sun, Moli and Zhonggui He, Formulation of Nanosuspension as a new Approach for the Delivery of Poorly Soluble Drugs. Current nanoscience. 2009, 5: 417-27.
15. Shivanand P, Devmurari V, Manish G, Ashapuri H. Nanosuspension: Formulation, Characterization and Evaluation. International Journal of Pharma and Bio Sciences. 2010, V1(2).1-10.
16. Shah P, Bhalodia D, Shelat P. Nanoemulsion: A Pharmaceutical Review. Systematic Reviews in Pharmacy, 2010, Vol.1, Issue: 1, Page: 24-32.
17. Jae-Woon N,Yun-Woong P, Young-Il J, Dong-Woon K, Chong-Su C, Sung-Ho K, Myung-Yul Kim. Clonazepam Release from Poly (dl Lactideco-Glycolide) Nanoparticles Prepared by Dialysis Method. Arch. Pharm. Res., 1998, vol.21, no.4, 418-22.
18. Didier B, Sandrine S,Jean-Philippe L, Josette de N, Alain E, Jean-Marie Z, Bernard F. Biovector Nanoparticles Improve Antinociceptive Efficacy of Nasal Morphine. Pharmaceutical Reserch. 2000, Vol. 17, No. 6, 743-47.
19. Lee K.Y, Kim J.H, Kwon I.C, Jeong S.Y. Self Aggregates of Deoxycholic Acid - Modified Chitosan as a Novel Carrier of Adriamycin. Colloid and polymer science, 2000, 278:1216-19.
20. Maria G.C, Paola M. P, Luygi L. Release of Dexamethasone from PLGA Nanoparticles Entrapped into Dextran/Poly (Vinyl alcohol) Hydrogels. Journal of material science: materials in medicine, 2002.13: 265-69.
21. Jugminder S.C and Mansoor M.A, Biodegradable poly (caprolactone) Nanoparticles for tumor-targeted delivery of Tamoxifen. International Journal of Pharmaceutics, 2002, Vol. 249, Iss.1-2,127-38.
22. Timothy J.Y, Keith P.J, Gary W.P. Awadhesh K.M. Phospholipid- Stabilized Nanoparticles of Cyclosporine a by Rapid Expansion from Supercritical to Aqueous Solution. AAPS Pharm Sci.Tech, 2003, 5(1), article 11.1-16.
23. Umamaheshwari R.B, Suman R, Narendra Kumar. Anti- Helicobacter Pylori Effect of Mucoadhesive Nanoparticles Bearing Amoxicillin in Experimental Gerbils Model. AAPS PharmSciTech.www.aapspharmscitech.org/articles/pt0502/pt 050232/pt050232.pdf 2004
24. Hannele. E, Leena P, Janne.R, Jouni.H, Esko. I.K, Nanoparticles Containing Ketoprofen and Acrylic Polymers Prepared by an Aerosol Flow Reactor Method. Available at www.springerlink.com/index/U33605571HMT4N80.pdf.accesse d on January 2004.
25. Rubiana M. M, Raul C. E. PLGA Nanoparticles Containing Praziquantel: Effect of Formulation Variables on Size Distribution. International journal of pharmaceutics, 2005, 296: 137-44.
26. Yongli Z, Yan W, Wuli Y, Changchun W, Shoukuan F, Xizhong S. Preparation, Characterization, and Drug Release In vitro of Chitosan Glycyrrhetic Acid Nanoparticles. Wiley Interscience (www. Interscience.wiley.com). 2005, 181-91.
27. Saikat D, Rinti B, Jayesh B. Aspirin Loaded Albumin Nanoparticles by Coacervation: Implications in Drug Delivery. http://www.sbaoi.org. 2005, vol 18(2).203-12.
28. So Yeon K, Young M L, Ju Seop K. Indomethacin-Loaded Methoxy Poly(ethylene glycol)/Poly(D,L-Lactide) Amphiphilic Diblock Copolymeric Nanospheres: Pharmacokinetic and Toxicity Studies in Rodents. Available at http://www.interscience.wiley.com DOI: 10.1002/jbm.a.30342. Accessed on15 July 2005.
29. Mohamed.N. K, Pierre.S, Didier.H, Alce. D, Jean-Christophe. L, Long Circulating poly(ethelene glycol)- Decorated Lipid Nanocapsules Deliver Docetaxel to Solid Tumors. Pharmaceutical research, 2006, vol.23, no.4.752-75.
30. Hariharn S, Bhardwaj V, Bala l, Sitterberg J, Bakowsky U, Ravikumar MN. Design of Estradiol loded PLGA Nanoparticulate Formulations: A Potential oral delivery system for hormone therapy. Pharmaceutical Research. 2006, 23(1); 184-95.
31. Jana S T, Wolfgang M, Tobias B, Burkhard K, R Sivaramakrishnan, Christos C. Z, Holger S, Hans C K, Klaus D. K, and Monika S fer-Korting. Cyproterone Acetate Loading to Lipid Nanoparticles for Topical Acne Treatment: Particle Characterization and Skin Uptake. Pharmaceutical research. 2007, Vol. 24, No. 5.991-1000.
32. So Hee.N, Hye.Y. N, Jae R. J.In Su B, Jong-Sang P, Curcumin- Loaded PLGA Nanoparticles Coating onto Metals Stent by Electrophoretic Deposition techniques. Bulletin of the Korean chemical Society, 2007, vol.28. no.3, 397-402.
33. Carolina M M, Angélica P d M, Renata d L, André H R, Eneida d P, Leonardo F F. Initial Development and Characterization of PLGA Nanospheres Containing Ropivacaine. The journal of biological physics. 2007, 33:455-61.
34. Bhavna. Ahmad F.J., Khar R.K, Sultan. S, Bhatnagar A. Techniques to Develop and Characterize Nanosized Formulation for Salbutamol Sulfate. Journal of material science: materials in medicine, http://www.spingerlink.com/doi:10. 1007/s/0856-008-3483-5. Accessed on 10 june 2008.
35. Amandeep. K, Subheet J, Ashok K. T,(2008) Mannan-Coated Gelatin Nanoparticles for Sustained and Targeted Delivery of Didanosine: In vitro and In vivo Evaluation. Acta Pharmaceutica sciencia. 2008, 58: 61-74.
36. Tamizharsi S, Shukla A, Shivakumar T, Rathi V, Rathi J.C. Formulation and Evaluation of Lamivudine Loded Polymethaacrylic Acid Nanoparticles. International Journal of Pharmaceutical Technology and Research. 2009, Vol.1, no.3, 411-15.
37. Amber V, Shailendra S, Swarnalatha S. Encapsulation of Cyclodextrin complexed Simvastatin in Chitosan Nanocarriers. A Novel Technique for Oral Delivery. Journal of Inclusion Phenomena and Macrocyclic Chemistry.2010, 66,251-59.
38. Kalaria D.R, Sharma G, Beniwal V, Ravi Kumar M.N.V. Design of Biodegradable Nanoparticles for Oral Delivery of Doxorubicin: In vivo Pharmacokinetics and Toxicity Studies in Rats. Pharmaceutical Research, 2009, Vol. 26, No. 3.492-501.
39. Italia J.L, Yahya M.M, Singh. D, Ravi Kumar M.N.V, Biodegradable Nanoparticles Improve Oral Bioavailability of Amphotericin B and Show Reduced Nephrotoxicity Compared to Intravenous Fungizone®. Pharmaceutical Research, 2009, Vol. 26, No. 6: 1324-31.
40. Jean C. Sung,1 Danielle J. Padilla,2 Lucila Garcia-Contreras, Jarod L. VerBerkmoes, David Durbin,.Charles A. Peloquin, Katharina J. Elbert, Anthony J. Hickey, and David A. Edwards. Formulation and Pharmacokinetics of Self-Assembled Rifampicin Nanoparticle Systems for Pulmonary Delivery. Pharmaceutical research, 2009, Vol. 26, No. 8.1847-55.
41. 4 Induced Acute Liver Failure. Available at www.springerlink.com/index/v82672572024872 x.pdf. 2008.
42. Min S, Yan G, Chenyu G, Fengliang C, Zhimei S, Yanwei X, Aihua Y, Aiguo L, Guangxi Z. (2010). Enhancement of Transport of Curcumin to Brain in Mice by Poly(n-Butylcyanoacrylate) Nanoparticle. Journal of Nanoresearch, 2010, 12; 3111-22.
43. Rui C, Yong Q, Rui L, Qing Z, Dongfei L, Miao W, and Qunwei X. Methazolamide Calcium Phosphate Nanoparticles in an Ocular Delivery System., 2010, 130(3): 419-24.
44. Haripriya S, Vadivel E, Ilamurugu K, Venkatachalam R. Preparation of Withaferin A loaded PLGA Nanoparticles by Modified Emulsion Diffusion Evaporation Techniques. International journal of nanotechnology and applications, 2010, Vol. 4, No. 2,163-68.
45. Heike B, Markus Drechsler, Michel H. J. Koch, and Kirsten Westesen. Incorporation of the Model Drug Ubidecarenone into Solid Lipid Nanoparticles. Pharmaceutical research, 2001, Vol. 18, No. 3,. 287-93.
46. Yifan L, Dawei C, Li Xiang R, Xiuli Z, Jing Q. Solid Lipid Nanoparticles for Enhancing Vinpocetine's Oral Bioavailability. Journal of controlled release, 2006, 114:53-59.
47. Harivardhan Reddy L, Jawahar Singh A, Srinirasa Rao B, Dwarakanath, Rakesh Kumar Sharma, Ramachandra Murthy R. Tumoricidal Effects of Etoposide Incorporated Into Solid Lipid Nanoparticles After Intraperitoneal Administration in Dalton ' s Lymphoma Bearing Mice. The AAPS Journal, 2006, 8 (2).E254- E262.
48. Jie L, Wen Hu, Huabing C, Qian Ni, Huibi Xu, Xiangliang Y. Isotretinoin- Loaded Solid Lipid Nanoparticles with Skin Targeting for Topical Delivery. International journal of pharmaceutics, 2007, 328:191-95.
49. Kui Kui r, Dawei C, Rongqing Z, Liping X, Hongzhong W. Studies on Oridonin Solid Lipid Nanoparticles Preparation and Pharmacodynamics. Asian journal of pharmaceutical sciences, 2008, 3(2): 88-93.
50. Swrupananda M, Subhabrata R, Thakur R.S. Design and Evaluation of Itrconazole Loaded Solid Lipid Nanoparticulate System for Improving the Antifungal Therapy. Pak. J. pharm.Sci, 2009, vol.22, no.2, 131-38.
51. Lian Dong Hu, Qianbin X, Jian M, Chuang S. Preparation and Enhanced Oral Bioavailability of Cryptotanshinone Loaded Solid Lipid Nanoparticles. AAPS pharmSciTech. Available at www.springerlink.com/index/e1w655770p262rt2.pdf. Accessed on 18 june 2010.
52. Alok M, Shashi A, Yashwant G, Jain S.K. Body Distribution and Stability Studies on Mitoxantrone Loaded Solid Lipid Nanoparticles Conjugated with Concanavalin A. International journal of pharmacy and pharmaceutical sciences, 2010, Vol 2, Issue 2:39-42.
53. Kayser. O, Nanosuspensions for the Formulation of Aphidicolin to Improve Drug Targeting Effects Against Leishmania Infected Macrophages. International journal of pharmaceutics, 2000, 196: 253-56.
54. Rosario P, Nadia R, Claudio B, Francesco M, Adriana M, and Giovanni P. (2006) Preparation and Characterization of Eudragit Retard Nanosuspensions for the Ocular Delivery of Cloricromene. AAPS PharmSciTech; 2006, 7 (1) Article 27. E1- E7.
55. Norma Hernandez-Kirstein. Development and characterization of buparvaquone nanosuspensions for pulmonary delivery in the treatment of Pneumocystis pneumonia. Berlin, 2006.
56. Zhang X, Xia Q, Gu N. Preparation of All-Trans Retinoic Acid Nanosuspensions Using a Modified precipitation Method. Drug Development and Industrial Pharmacy, 2006, 32:857-63.
57. Jan L. W. Po. Chang. C, Sarbani G, Chad J. W, Steve P.W, Lesley A.A, Mark E. S, Steven L. R. Pharmacokinetic Evaluation of a 1, 3-Dicyclohexylurea Nanosuspension Formulation to Support Early Efficacy Assessment. Journal of nano research Available at www.springerlink.com/index/A534J3827K2411J9.pdf. accessed on 12th june 2007
58. Muthu M.S and Singh S. Poly (D, L-Lactide) Nanosuspensions of Risperidone for Parenteral Delivery: Formulation and In-Vitro Evaluation. Current drug delivery, 2009, 6: 62-68.
59. Panchaxari D, Shashidhar K, Vinayak M, Anand G and Anandrao K. Polymeric Ocular Nanosuspension for Controlled Release of Acyclovir: In vitro Release and Ocular Distribution. Iranian Journal of pharmaceutical research. 2009, 8 (2): 79-86.
60. Arunkumar N, Deecaraman M, Rani C, Mohanraj K.P, Venkates Kumar K. Preparation and Solid State Characterization of Atorvastatin Nanosuspensions for Enhanced Solubility and Dissolution. International journal of pharmaceutical technology and research, 2009, Vol.1, No.4, 1725-30.
61. Prabhat R. M, Loaye A, Rainer H. M, Cornelia M.K. Production and Characterization of Hespertin Nanosuspensions for Transdermal Delivery. International journal of pharmaceutics, 2009, vol.371, Issues 1-2, 182-89.
62. Ambrus R, Kocbe.P, Kristl.J, Sibanc. R, Rajko. R, Szabo-Revesz. P. Investigation of Preparation Parameters to Improve the Dissolution of Poorly Water-Soluble Meloxicam; International journal of pharmaceutics. 2009, 381: 153-59.
63. Shivanand P., Itraconazole Nanosuspension Meant for Oral Use: Development of Formulation, Characterization and In Vitro Comparison with Some Marketed Formulations. Der Pharmacia Lettre, 2010: 2 (1) 162-171
64. Saurabh G, Malay K, Samanta, Ashok.M. Dual Drug Delivery system based on In situ Gel-forming Nanosuspension of Forskolin to Enhance Antiglaucoma Efficacy. AAPS PharmSciTech 2010, vol.11, no.1, 322-35.
65. Yancci W, Dianuri Z, Zhaoping L, Guangpu L, Cunxian D, Lejiao J, Feifei F, Xiaoyu S, Qiang Z. In vitro & In vivo Evaluation of Silybin Nanosuspensions for Oral and Intravenous Delivery, Nanotechnology,http://www.iopscience.iop.org/0957-4484 /21/15 /.../0957 4484_21_15_155104.pdf, 2010.
66. Ana M.C, Marco M, Bruno. G. Miconazole Nanosuspensions: Influence of Formulation Variables on Particle Size Reduction and Physical Stability. International Journal of Pharmaceutics, 2010, Vol.396, Issue 1-2, 210-18.
67. Amit R P, Murthy R.S.R. Preparation of Intramuscular Nanosuspension of Water Insoluble Drug (Diclofenac Base) for Sustained Release. Available at www.aapsj.org/abstracts /AM_2008/AAPS2008-001706.PDF. 2010.
68. Vikram M P, Jayvadan K P, Dhaval J P. Effect of Different Stabilizer on the Formulation of Simvastatin Nanosuspension Prepared by Nanoprecipitation Technique. Research Journal of Pharmaceutical, Biological and Chemical Sciences. 2010, 1(4): 910-17.
69. Dhaval j. Patel, Jayvadan K.Patel. Mucoadhesive Effect of Polyethyleneoxide on Famotidine Nanosuspension Prepared by Solvent Evaporation Method. International journal of pharmacy and pharmaceutical sciences, 2010, Vol 2, Suppl 2,. 122-27.
70. th World meeting on Pharmaceutics, Biopharmaceutics and Pharm. Tech, Geneva, 2006.
71. Boon-Seang C, Sosaku I, Sunuya K, Mitsutoshi N. Preparation of stabilized β- Carotene Nanodispersions by Emulsification- Evaporation Method. Journal of the American Oil Chemists' Society, 2007, Vol.84, no. 11, 1053-62.
72. Faiyah S, Sanjula B, Alka A, Javed A, Mohammed A, Sheikh S. Nanoemulsions as Vehicles for Transdermal Delivery of Aceclofenac. AAPS PharmSciTech, 2007, 8(4):E1-E9
73. Faiyah S, Sanjula B, Alka A, Javed A, Mohammed A, Sheikh S. Skin Permeation Mechanism and Bioavailability Enhancement of Celecoxib from Transdermally Applied Nanoemulsion. Journal of Nanobiotechnology, available at www.jnanobiotechnology.com /content/6/1/8/abstract. 2008
74. Devika R. B, Hrushikesh M. J, Murali S, Varsha B. P. Chitosan Reduced Gold Nanoparticles as Novel Carriers for Transmucosal Delivery of Insulin. Available at www.springerlink.com/index/ j205251833w7l6t6.pdf. 2007
75. Harsimran K, Archana C, Inderpreet K, Kashmir S, Lalit M.B.(2010)Transportation of Drug- Gold Nanocomposites by Actinomyosin Motor System. Journal of nanoparticle research, Available at www.springerlink.com/index/D25H45525W575 65K.pdf. 2010.
76. Shankar S, Vavia P.R. Formulation of Betacyclodextrin Based Nanosponges of Itraconazole. Journal of inclusion Phenomena and Macrocyclic Chemistry, 2007, 57:89-94.
77. Torne S J, Ansari K A, Vavia P R, Trotta F, Cavalli R, Enhanced oral paclitaxel bioavailability after administration of paclitaxel- loded nanosponges., available at www.ncbi.nlm.nih.gov /pubmed/20429848. 2010.